This study was aimed to verify the efficacy and safety of ibuprofen prophylaxis of patent ductus arteriosus in very preterm infants, in order to select infants receiving higher benefits from this intervention. Two hundred neonates with gestational age (GA) < or = 28 weeks receiving ibuprofen within the first two hours of life were included. Ductus closure rate was 68%, and results were significantly dependent on GA (48.8% among neonates with GA < 26 weeks vs 73.2% among those with GA > or = 26 weeks, p < 0.01). Neonates with GA < 26 weeks showed a lower ductus closure after the primary course of therapy (20% vs 57.5%, p < 0.01), as well as higher reopening rate (16.2% vs 3.8%, p < 0.05) and need for surgical ligation (38.8% vs 5.8%, p < 0.01). During the prophylaxis period, 11 neonates (5.5%) showed pulmonary hypertension. Considering risks/benefits, we recommend prophylaxis only in infants with GA < 26 weeks

Bersani, I., De Carolis, M. P., Lacerenza, S., De Rosa, G., Cota, F., Fusco, F. P., Romagnoli, C., Is the prophylaxis of patent ductus arteriosus useful in extremely prematureinfants?, <<TURKISH JOURNAL OF PEDIATRICS>>, 2011; (53 (2)): 187-193 [http://hdl.handle.net/10807/3807]

Is the prophylaxis of patent ductus arteriosus useful in extremely premature infants?

Bersani, Iliana;De Carolis, Maria Pia;Lacerenza, Serafina;De Rosa, Gabriella;Cota, Francesco;Fusco, Francesca Paola;Romagnoli, Costantino
2011

Abstract

This study was aimed to verify the efficacy and safety of ibuprofen prophylaxis of patent ductus arteriosus in very preterm infants, in order to select infants receiving higher benefits from this intervention. Two hundred neonates with gestational age (GA) < or = 28 weeks receiving ibuprofen within the first two hours of life were included. Ductus closure rate was 68%, and results were significantly dependent on GA (48.8% among neonates with GA < 26 weeks vs 73.2% among those with GA > or = 26 weeks, p < 0.01). Neonates with GA < 26 weeks showed a lower ductus closure after the primary course of therapy (20% vs 57.5%, p < 0.01), as well as higher reopening rate (16.2% vs 3.8%, p < 0.05) and need for surgical ligation (38.8% vs 5.8%, p < 0.01). During the prophylaxis period, 11 neonates (5.5%) showed pulmonary hypertension. Considering risks/benefits, we recommend prophylaxis only in infants with GA < 26 weeks
Inglese
Bersani, I., De Carolis, M. P., Lacerenza, S., De Rosa, G., Cota, F., Fusco, F. P., Romagnoli, C., Is the prophylaxis of patent ductus arteriosus useful in extremely prematureinfants?, <<TURKISH JOURNAL OF PEDIATRICS>>, 2011; (53 (2)): 187-193 [http://hdl.handle.net/10807/3807]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/3807
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 4
social impact